US2007129282A1PendingUtilityA1

Pharmaceutical treatments and compositions

54
Assignee: AHLEM CLARENCE NPriority: Nov 24, 1998Filed: Jun 24, 2004Published: Jun 7, 2007
Est. expiryNov 24, 2018(expired)· nominal 20-yr term from priority
A61P 35/00C07J 1/0025A61K 31/56C07J 1/0011C07J 31/006C07J 31/003Y02A50/30
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compositions comprising formula 1 steroids, e.g., 16α-bromo-3β-hydroxy-5α-androstan-17-one hemihydrate and one or more excipients, including compositions that comprise a liquid formulation comprising less than about 3% v/v water. The compositions are useful to make improved pharmaceutical formulations. The invention also provides methods of intermittent dosing of steroid compounds such as analogs of 16α-bromo-3β-hydroxy-5α-androstan-17-one and compositions useful in such dosing regimens. The invention further provides compositions and methods to inhibit pathogen replication, ameliorate symptoms associated with immune dysregulation and to modulate immune responses in a subject using the compounds. The invention also provides methods to make and use these immunomodulatory compositions and formulations.

Claims

exact text as granted — not AI-modified
1 - 30 . (canceled)  
   
   
       31 . A compound having the structure  
     
       
         
         
             
             
         
       
     
   
   
       32 . A pharmaceutical formulation comprising one or more excipients and a compound having the structure

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.